The Spinal Muscular Atrophy market is estimated to be valued at US$ 1813.48 Mn in 2023 and is expected to exhibit a CAGR of 13% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.
SWOT Analysis:
· Strength: Spinal Muscular Atrophy market has strong pipeline drugs in late stage...
English
Arabic
Français
Español
Português
Deutsch
Türkçe
Dutch
Italiano
Russian